{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:15:24Z","timestamp":1770070524370,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[1985,12,1]],"date-time":"1985-12-01T00:00:00Z","timestamp":502243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1985,12]]},"DOI":"10.1007\/bf01733779","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T11:26:15Z","timestamp":1118661975000},"page":"1205-1211","source":"Crossref","is-referenced-by-count":124,"title":["Pharmacokinetics of oral and intravenous rifampicin during chronic administration"],"prefix":"10.1007","volume":"63","author":[{"given":"U.","family":"Loos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Musch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mikus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. K.","family":"Schwabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Eichelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01733779_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/gut.13.1.47","volume":"13","author":"G Acocella","year":"1972","unstructured":"Acocella G, Bonollo L, Garimoldi M, Mainardi M, Tenconi LT, Nicolis FB (1972) Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease. Gut 13:47\u201353","journal-title":"Gut"},{"key":"BF01733779_CR2","first-page":"1221","volume":"27","author":"G Acocella","year":"1977","unstructured":"Acocella G, Bonollo L, Mainardi M, Margaroli P, Tenconi LT (1977) Serum and urine concentrations of rifampicin administered by intravenous infusion in man. Arzneimittelforsch 27:1221\u20131226","journal-title":"Arzneimittelforsch"},{"key":"BF01733779_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0031-6989(78)80021-6","volume":"10","author":"G Acocella","year":"1978","unstructured":"Acocella G, Mattiussi R, Segre G (1978) Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week. Pharmacol Res Commun 10:271\u2013288","journal-title":"Pharmacol Res Commun"},{"key":"BF01733779_CR4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2165\/00003088-197803020-00002","volume":"3","author":"G Acocella","year":"1978","unstructured":"Acocella G (1978) Clinical pharmacokinetics of rifampicin. Clin Pharmacokin 3:108\u2013127","journal-title":"Clin Pharmacokin"},{"key":"BF01733779_CR5","first-page":"1907","volume":"21","author":"G Binda","year":"1971","unstructured":"Binda G, Domenichini E, Gottardi A, Orlandi B, Ortelli E, Pacini B, Fowst G (1971) Rifampicin, a general review. Arzneimittelforsch 21:1907\u20131977","journal-title":"Arzneimittelforsch"},{"key":"BF01733779_CR6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00560384","volume":"7","author":"G Boman","year":"1974","unstructured":"Boman G (1974) Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid. Europ J Clin Pharmacol 7:217\u2013225","journal-title":"Europ J Clin Pharmacol"},{"key":"BF01733779_CR7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/cpt1977214470","volume":"21","author":"DD Breimer","year":"1977","unstructured":"Breimer DD, Zilly W, Richter E (1977) Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. Clin Pharmacol Ther 21:470\u2013481","journal-title":"Clin Pharmacol Ther"},{"key":"BF01733779_CR8","first-page":"534","volume":"17","author":"S Furesz","year":"1967","unstructured":"Furesz S, Scotti R, Pallanza R, Mapelli E (1967) Rifampicin: a new rifamycin. Arzneimittelforsch 17:534\u2013537","journal-title":"Arzneimittelforsch"},{"key":"BF01733779_CR9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003088-198409060-00003","volume":"9","author":"MR Holdiness","year":"1984","unstructured":"Holdiness MR (1984) Clinical pharmacokinetics of the antituberculosis drugs. Clin Pharmacokin 9:511\u2013544","journal-title":"Clin Pharmacokin"},{"key":"BF01733779_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00007691-198303000-00005","volume":"5","author":"G Houin","year":"1983","unstructured":"Houin G, Beucler A, Richelet S, Brioude R, Lafaix C, Tillement JP (1983) Pharmacokinetics of rifampicin and desacetylrifampicin in tuberculous patients after different rates of infusion. Ther Drug Monit 5:67\u201372","journal-title":"Ther Drug Monit"},{"key":"BF01733779_CR11","unstructured":"Keberle H, Kr\u00fcger-Thiemer E, Sackmann W, Schmid K, Seydel J (1967) Pharmakokinetische Untersuchungen an Rifampicin. In: Spitzy KH, Haschek H (eds) Proc 5th Int Congr Chemotherapy, Wien. Vol 4, pp 157\u2013160"},{"key":"BF01733779_CR12","first-page":"20","volume-title":"A symposium on RimactaneR","author":"H Keberle","year":"1968","unstructured":"Keberle H, Schmid K, Meyer-Brunot HG (1968) The metabolic fate of Rimactane in the animal and in man. In: Dettli L (ed) A symposium on RimactaneR. Ciba, Basel, pp 20\u201327"},{"key":"BF01733779_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/03602538109011084","volume":"12","author":"MT Kenny","year":"1981","unstructured":"Kenny MT, Strates B (1981) Metabolism and pharmacokinetics of the antibiotic rifampin. Drug Metab Rev 12:159\u2013218","journal-title":"Drug Metab Rev"},{"key":"BF01733779_CR14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1248\/yakushi1947.104.8_884","volume":"14","author":"H Kohno","year":"1984","unstructured":"Kohno H, Hata B, Tsuchiya T, Kubo H (1984) Enzyme induction by rifampicin and its time-dependent pharmacokinetics. Yakugaka Zasski (=J Pharmacol Soc Japan) 14:884\u2013888","journal-title":"Yakugaka Zasski"},{"key":"BF01733779_CR15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0378-4347(00)81356-0","volume":"145","author":"JB Lecaillon","year":"1978","unstructured":"Lecaillon JB, Febvre N, Metayer JP, Souppart C (1978) Quantitative assay of rifampicin and three of its metabolites in human plasma, urine and saliva by high-performance liquid chromatography. J Chromatogr 145:319\u2013324","journal-title":"J Chromatogr"},{"key":"BF01733779_CR16","first-page":"482","volume":"37","author":"U Loos","year":"1983","unstructured":"Loos U, Musch E, Mackes KG, Reetz KP, Gl\u00e4ser R, v. Sassen W, Labedzki L, Schwabe HK, Hengstmann J, Eichelbaum M (1983) Vergleich oraler und intraven\u00f6ser Rifampicin-Gabe bei der Behandlung offener Lungentuberkulosen. Prax Klin Pneumol 37:482\u2013484","journal-title":"Prax Klin Pneumol"},{"key":"BF01733779_CR17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jac\/5.4.447","volume":"5","author":"RP Mouton","year":"1979","unstructured":"Mouton RP, Mattie H, Swart K, Kreukniet J, de Wael J (1979) Blood levels of rifampicin, desacetylrifampicin and isoniazid during combined therapy. J Antimicrob Chemotherapy 5:447\u2013454","journal-title":"J Antimicrob Chemotherapy"},{"key":"BF01733779_CR18","first-page":"638","volume":"88","author":"E Musch","year":"1982","unstructured":"Musch E, Loos U, Mackes KG, Reetz KP, Gl\u00e4ser R, v. Sassen W, Labedzki L, Schwabe HK, Hengstmann J, Eichelbaum M (1982) Klinische Verlaufsstudie bei intraven\u00f6ser Rifampicinapplikation in the Tuberkulosetherapie. Verh Dtsch Ges Inn Med 88:638\u2013644","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"BF01733779_CR19","unstructured":"Nakagawa H, Sunahara S (1975) Glucuronidation and desacetylation in the metabolism of rifampicin in man. 23 rd Int Tuberculosis Conf, Mexico City. Cited by Acocella (4)"},{"key":"BF01733779_CR20","first-page":"171","volume":"54","author":"H Nakagawa","year":"1979","unstructured":"Nakagawa, H, Umene Z, Sunahara S (1979) Increased desacetyl-rifampicin and adverse reactions. Bull Int Union Against Tuberculosis 54:171\u2013172","journal-title":"Bull Int Union Against Tuberculosis"},{"key":"BF01733779_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000221963","volume":"23","author":"V Nitti","year":"1977","unstructured":"Nitti V, Virgilio R, Patricolo MR, Iuliano A (1977) Pharmacokinetic study of intravenous rifampicin. Chemotherapy 23:1\u20136","journal-title":"Chemotherapy"},{"key":"BF01733779_CR22","first-page":"36","volume-title":"A symposium on RimactaneR","author":"W Riess","year":"1968","unstructured":"Riess W (1968) The optimum dosage schedule for Rimactane. In: Dettli L (ed) A symposium on RimactaneR. Ciba, Basel, pp 36\u201342"},{"key":"BF01733779_CR23","first-page":"224","volume":"1","author":"H Remmer","year":"1973","unstructured":"Remmer H, Schoene B, Fleischmann RA (1973) Induction of the unspecific microsomal hydroxylase in the human liver. Drug Metab Disp 1:224\u2013230","journal-title":"Drug Metab Disp"},{"key":"BF01733779_CR24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jps.2600610111","volume":"61","author":"M Rowland","year":"1972","unstructured":"Rowland M (1972) Influence of route of administration on drug availability. J Pharm Sci 61:70\u201374","journal-title":"J Pharm Sci"},{"key":"BF01733779_CR25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/978-3-662-05749-0","volume-title":"Angewandte Statistik","author":"L Sachs","year":"1974","unstructured":"Sachs L (1974) Angewandte Statistik, 4th edn. Springer, Berlin Heidelberg New York, p 426","edition":"4th edn."},{"key":"BF01733779_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(74)91487-1","volume":"II","author":"DI Siegler","year":"1974","unstructured":"Siegler DI, Bryant M, Burley DM, Citron KM (1974) Effect of meals on rifampicin absorption. Lancet II, 197\u2013198","journal-title":"Lancet"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01733779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01733779\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01733779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T14:11:24Z","timestamp":1557324684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01733779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,12]]},"references-count":26,"journal-issue":{"issue":"23","published-print":{"date-parts":[[1985,12]]}},"alternative-id":["BF01733779"],"URL":"https:\/\/doi.org\/10.1007\/bf01733779","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,12]]}}}